Highlights
1 patentProfile claimed by owner
About
Pioneering Hybrid Drugs
Remepy is pioneering hybrid drugs, and redefining combination therapy. Its mission is to bring better personalized care to patients.
Remepy’s Digital molecules are mobile applications designed for hybrid drug experiences, each containing a unique digital treatment protocol. Its Digital molecules include digitized, standardized, evidence-based interventions, designed to enhance brain plasticity and connectivity, balance the immune system, and drive behavioral changes. The company addresses disease end-points as well as side-effects and disease comorbidities.
Remepy partners with pharma companies to bring Hybrid Drugs to market that will combine Remepy’s Digital Molecule and traditional drug components.
Identity
| Name | Remepy |
|---|---|
| Slug | remepy |
| Type / kind | startup |
| Source _id | qn37nCmnQBXpvy69EXNTyhIyfQLcj9yYRxZGEBaKyPKueHT9aUIx2q |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Ramat Gan |
| HQ address | Ramat Gan, Israel |
Web & social
| Website | https://www.remepy.com/ |
|---|---|
| Careers page | https://www.remepy.com/careers |
| https://www.linkedin.com/company/82435157 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2BB2B2C
Tags
digital-healthcaresaasdrug-discoverydrug-developmentpharmaceuticals
Funding
| Total raised | $25.0M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}